Gene · 442908
Papers1,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Brain microRNA profiles after exposure to heroin in rats. | Exp Brain Res | 2024 | 39671092 | PubTator, text mining | PubMed |
| Prognostic Value of miR-10a-3p in Non-Small Cell Lung Cancer Patients. | Onco Targets Ther | 2024 | 39559728 | PubTator, text mining | PubMed |
| Bioinformatic Analysis from a Descriptive Profile of miRNAs in Chronic Migraine. | Int J Mol Sci | 2024 | 39408819 | PubTator, text mining | PubMed |
| [Corrigendum] Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines. | Int J Mol Med | 2024 | 39364752 | PubTator, text mining | PubMed |
| Noncoding Ribonucleic Acids (RNAs) May Improve Response to Immunotherapy in Pancreatic Cancer. | ACS Pharmacol Transl Sci | 2024 | 39296265 | PubTator, text mining | PubMed |
| miRNAs and NFKB1 and TRAF6 target genes: The initial functional study in CD14+ monocytes in rheumatoid arthritis patients. | Genet Mol Biol | 2024 | 39058384 | PubTator, text mining | PubMed |
| MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort study. | Int J Surg | 2024 | 39041944 | PubTator, text mining | PubMed |
| M6A-mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8+ T cells and phagocytosis of macrophages. | Adv Sci (Weinh) | 2024 | 38981064 | PubTator, text mining | PubMed |
| Exploring the potential of predicted miRNAs on the genes involved in the expansion of hematopoietic stem cells. | Sci Rep | 2024 | 38969714 | PubTator, text mining | PubMed |
| The potential of five c-miRNAs as serum biomarkers for Late-Onset Alzheimer's disease diagnosis: miR-10a-5p, miR-29b-2-5p, miR-125a-5p, miR-342-3p, and miR-708-5p. | Brain Res | 2024 | 38880411 | PubTator, text mining | PubMed |
| Correction: Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340. | Mol Cancer | 2024 | 38741180 | PubTator, text mining | PubMed |
| Retraction: Long non-coding RNA SNHG14 exerts oncogenic functions in non-small cell lung cancer through acting as a miR-340 sponge. | Biosci Rep | 2024 | 38682478 | PubTator, text mining | PubMed |
| The Involvement of the microRNAs miR-466c and miR-340 in the Palmitate-Mediated Dysregulation of Gonadotropin-Releasing Hormone Gene Expression. | Genes (Basel) | 2024 | 38674332 | PubTator, text mining | PubMed |
| Investigation of key miRNAs and Target-mRNA in Kaposi's sarcoma using bioinformatic methods. | Heliyon | 2024 | 38660282 | PubTator, text mining | PubMed |
| Correlation analysis of bone marrow microvessel density and miRNA expression on drug resistance in patients with chronic myelogenous leukemia after tyrosine kinase inhibitor treatment. | Hematology | 2024 | 38299685 | PubTator, text mining | PubMed |
| Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway. | J Transl Med | 2024 | 38282047 | PubTator, text mining | PubMed |
| Alzheimer's Disease: Models and Molecular Mechanisms Informing Disease and Treatments. | Bioengineering (Basel) | 2024 | 38247923 | PubTator, text mining | PubMed |
| Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets. | Medicine (Baltimore) | 2024 | 38241548 | PubTator, text mining | PubMed |
| CircPOFUT1 fosters colorectal cancer metastasis and chemoresistance via decoying miR-653-5p/E2F7/WDR66 axis and stabilizing BMI1. | iScience | 2024 | 38230259 | PubTator, text mining | PubMed |
| Lentinan progress in inflammatory diseases and tumor diseases. | Eur J Med Res | 2024 | 38172925 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442908/papers?page=2